• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday

    4/19/24 10:40:21 AM ET
    $ALVO
    $AMC
    $BHB
    $CNS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Movies/Entertainment
    Consumer Discretionary
    Get the next $ALVO alert in real time by email

    U.S. stocks were mixed, with the Nasdaq Composite falling over 100 points on Friday.

    Shares of Fifth Third Bancorp (NASDAQ:FITB) rose during Friday's session after the company reported better-than-expected quarterly financial results.

    Fifth Third Bancorp posted adjusted earnings of 76 cents per share, beating market estimates of 70 cents per share. The company's sales came in at $2.100 billion versus expectations of $2.086 billion, according to data from Benzinga Pro.

    Fifth Third Bancorp shares gained 4.2% to $35.67 on Friday.

    Here are some other big stocks recording gains in today's session.

    • Mobile-health Network Solutions (NASDAQ:MNDR) shares jumped 20.2% to $24.53.
    • Metropolitan Bank Holding Corp. (NYSE:MCB) rose 19% to $39.40 after the company reported better-than-expected first-quarter financial results.
    • Humacyte, Inc. (NASDAQ:HUMA) climbed 12.2% to $4.03.
    • Paramount Global (NASDAQ:PARA) shares rose 9.7% to $12.03 following reports suggesting Sony is in talks with Apollo to join a bid for the company.
    • Cohen & Steers, Inc. (NYSE:CNS) gained 8.1% to $71.48 after it was announced the stock will join the S&P SmallCap 600.
    • Tellurian Inc. (NYSE:TELL) shares jumped 7.8% to $0.4172.
    • Alvotech (NASDAQ:ALVO) gained 6.6% to $13.75. Alvotech inked a long-term agreement with a strategic partner to further enhance access to Adalimumab-ryvk in the US market.
    • Bar Harbor Bankshares (NYSE:BHB) climbed 5.6% to $25.20 following upbeat quarterly earnings.
    • Nuvation Bio Inc. (NYSE:NUVB) rose 5.2% to $2.7150.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) shares rose 4.8% to $3.0589. Wedbush, on Thursday, slashed its price target on the stock to $4 on Thursday.
    • Community Health Systems, Inc. (NYSE:CYH) gained 4.7% to $2.9099. Community Health Systems announced an agreement to sell Cleveland, Tennessee, Hospital to Hamilton Health Care System for $160 million in cash.

    Read More: Netflix To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday

    Get the next $ALVO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALVO
    $AMC
    $BHB
    $CNS

    CompanyDatePrice TargetRatingAnalyst
    Fifth Third Bancorp
    $FITB
    1/6/2026$57.00Neutral → Buy
    UBS
    Alvotech
    $ALVO
    12/9/2025$5.00Underweight
    Barclays
    Nuvation Bio Inc.
    $NUVB
    11/24/2025Buy
    Truist
    Nuvation Bio Inc.
    $NUVB
    11/19/2025$12.00Buy
    B. Riley Securities
    Alvotech
    $ALVO
    11/4/2025$8.00Buy → Hold
    Deutsche Bank
    Alvotech
    $ALVO
    10/14/2025$14.00Equal-Weight → Overweight
    Morgan Stanley
    Fifth Third Bancorp
    $FITB
    10/14/2025$52.00Equal-Weight → Overweight
    Stephens
    Fifth Third Bancorp
    $FITB
    10/7/2025$60.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $ALVO
    $AMC
    $BHB
    $CNS
    SEC Filings

    View All

    AMC Entertainment Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AMC ENTERTAINMENT HOLDINGS, INC. (0001411579) (Filer)

    3/6/26 5:18:54 PM ET
    $AMC
    Movies/Entertainment
    Consumer Discretionary

    Community Health Systems Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Filer)

    3/5/26 5:00:28 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    Amendment: Fifth Third Bancorp filed SEC Form 8-K: Financial Statements and Exhibits

    8-K/A - FIFTH THIRD BANCORP (0000035527) (Filer)

    3/4/26 5:11:44 PM ET
    $FITB
    Major Banks
    Finance

    $ALVO
    $AMC
    $BHB
    $CNS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Colter David M bought $16,270 worth of shares (500 units at $32.54), increasing direct ownership by 4% to 12,687 units (SEC Form 4)

    4 - BAR HARBOR BANKSHARES (0000743367) (Issuer)

    3/3/26 12:46:35 PM ET
    $BHB
    Major Banks
    Finance

    Executive Chairman Steers Robert Hamilton bought $1,496,880 worth of shares (25,000 units at $59.88) (SEC Form 4)

    4 - COHEN & STEERS, INC. (0001284812) (Issuer)

    11/20/25 5:50:43 PM ET
    $CNS
    Investment Managers
    Finance

    Director Cohen Martin gifted 100,000 shares and bought $5,982,412 worth of shares (100,000 units at $59.82), increasing direct ownership by 12% to 949,205 units (SEC Form 4)

    4 - COHEN & STEERS, INC. (0001284812) (Issuer)

    11/20/25 5:50:18 PM ET
    $CNS
    Investment Managers
    Finance

    $ALVO
    $AMC
    $BHB
    $CNS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & Chief Financial Officer Dougherty Daniel F was granted 5,487 shares and covered exercise/tax liability with 1,631 shares, increasing direct ownership by 14% to 31,197 units (SEC Form 4)

    4 - Metropolitan Bank Holding Corp. (0001476034) (Issuer)

    3/4/26 5:25:05 PM ET
    $MCB
    Major Banks
    Finance

    Executive Vice President Rosenberg Nick was granted 4,241 shares and covered exercise/tax liability with 5,628 shares, decreasing direct ownership by 5% to 24,452 units (SEC Form 4)

    4 - Metropolitan Bank Holding Corp. (0001476034) (Issuer)

    3/4/26 5:25:06 PM ET
    $MCB
    Major Banks
    Finance

    EVP, Head of Retail Banking Capra Laura was granted 4,650 shares and covered exercise/tax liability with 1,705 shares, increasing direct ownership by 8% to 40,989 units (SEC Form 4)

    4 - Metropolitan Bank Holding Corp. (0001476034) (Issuer)

    3/4/26 5:20:05 PM ET
    $MCB
    Major Banks
    Finance

    $ALVO
    $AMC
    $BHB
    $CNS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Fifth Third upgraded by UBS with a new price target

    UBS upgraded Fifth Third from Neutral to Buy and set a new price target of $57.00

    1/6/26 9:08:22 AM ET
    $FITB
    Major Banks
    Finance

    Barclays initiated coverage on Alvotech with a new price target

    Barclays initiated coverage of Alvotech with a rating of Underweight and set a new price target of $5.00

    12/9/25 8:42:22 AM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Truist initiated coverage on Nuvation Bio

    Truist initiated coverage of Nuvation Bio with a rating of Buy

    11/24/25 8:30:57 AM ET
    $NUVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALVO
    $AMC
    $BHB
    $CNS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-2) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 10:44:05 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-1) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 2:59:28 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-3) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 2:59:28 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALVO
    $AMC
    $BHB
    $CNS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AMC Entertainment Holdings, Inc. Announces Commitment Letter With Respect to Refinancing of Its Odeon Notes

    AMC Entertainment Holdings, Inc. (NYSE:AMC) (the "Company," or "AMC"), announced today that the Company, together with its wholly-owned subsidiary Odeon Finco PLC ("Odeon"), have entered into a commitment letter with Deutsche Bank AG New York Branch providing for a new senior secured credit facility of Odeon in an aggregate principal amount of up to $425,000,000 (the "Odeon Credit Facility"). Odeon intends to use the proceeds of the Odeon Credit Facility, if consummated, to refinance its existing 12.750% Senior Secured Notes due 2027 (the "Odeon Notes") and pay related fees and expenses. The Odeon Credit Facility is expected to strengthen the Company's balance sheet, extend debt maturities,

    3/6/26 5:15:00 PM ET
    $AMC
    Movies/Entertainment
    Consumer Discretionary

    Community Health Systems Announces Definitive Agreement to Sell Four Arkansas Hospitals to Freeman Health System

    Community Health Systems, Inc. (NYSE:CYH) announced today that a subsidiary of the Company has signed a definitive agreement to sell substantially all of the assets of 128-bed Northwest Medical Center – Bentonville, in Bentonville, Arkansas, 222-bed Northwest Medical Center – Springdale in Springdale, Arkansas, 64-bed Northwest Medical Center – Willow Creek Women's Hospital in Johnson, Arkansas, and 73-bed Siloam Springs Regional Hospital in Siloam Springs, Arkansas, and the associated outpatient centers and practices, to Freeman Health System for $112 million, subject to certain adjustments based on closing net working capital and the amount of finance leases assumed by the buyer. The tr

    3/5/26 4:45:00 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    'THE STORY OF EVERYTHING' PRESENTS GROUNDBREAKING EVIDENCE THAT HAS REIGNITED THE DEBATE OVER SCIENCE, ORIGINS, AND THE EXISTENCE OF GOD IN THEATRES NATIONWIDE FROM FATHOM ENTERTAINMENT APRIL 30-MAY 6

    From the Team Behind 'When Calls the Heart' and 'After Death,' the Discovery Institute–Backed Feature Launches Its Official TrailerLee Strobel Boards as Executive Producer on Science-Driven Documentary Featuring Dr. Stephen C. Meyer and Jay W. RichardsNASHVILLE, Tenn. and DENVER, March 4, 2026 /PRNewswire/ -- A new feature documentary is about to challenge everything you thought science had settled about the origin of the universe—and the existence of God. The Story of Everything arrives in theatres nationwide April 30–May 6 from Fathom Entertainment, the leading specialty distributor of content to theatrical partners worldwide. The Story of Everything will bring to the big screen stunning n

    3/4/26 11:00:00 AM ET
    $AMC
    $CNK
    Movies/Entertainment
    Consumer Discretionary

    $ALVO
    $AMC
    $BHB
    $CNS
    Leadership Updates

    Live Leadership Updates

    View All

    Fifth Third Announces Three New Members to its Board of Directors

    New Directors join from Comerica's Board Fifth Third Bancorp (NASDAQ:FITB) today announced the appointment of Derek J. Kerr, Barbara R. Smith and Michael G. Van de Ven to its Board of Directors, effective February 1, 2026. "We're pleased to welcome Derek, Barbara and Mike to our Board," said Tim Spence, chairman, CEO and president of Fifth Third. "Each Director brings a distinctive combination of leadership and industry experience that will be an invaluable asset. Their perspectives, insight and experience will help guide the new Fifth Third as we continue to deliver innovative solutions for our customers and communities." Kerr is an experienced financial leader with broad and deep ex

    2/2/26 6:32:00 AM ET
    $FITB
    Major Banks
    Finance

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    Fifth Third Announces Credit Leadership Transition

    Fifth Third Bancorp (NASDAQ:FITB) today announced a planned leadership transition within its Credit organization following the upcoming retirement of Greg Schroeck, chief credit officer, after nearly 40 years of distinguished service. Kristof Schneider, currently deputy chief credit officer, will succeed Schroeck. Schneider will join Fifth Third's Enterprise management team, the Bank's senior-most governing body, and report to Bob Shaffer, chief risk officer. Schroeck will stay on in an advisory capacity through the second quarter of this year to ensure a smooth transition. Schroeck served more than 35 years with Fifth Third before retiring in 2021 and returning in 2023 to lead the Credit

    1/23/26 8:22:00 AM ET
    $FITB
    Major Banks
    Finance

    $ALVO
    $AMC
    $BHB
    $CNS
    Financials

    Live finance-specific insights

    View All

    Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results

    REYKJAVIK, Iceland, March 04, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO) (the "Company"), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it will release its fourth quarter and full year 2025 financial and operating results on Wednesday, March 18, 2026, after the U.S. markets close. The Company will also host a conference call with a live Q&A on Thursday, March 19, 2026 at 08:00 EST (12:00 GMT, 13:00 CET). To listen to the webcast, register here: Q4 and Full Year 2025 webcast registrationTo participate in the Q&A, register here: Q4 and Full Year 2025 conference call registration Slid

    3/4/26 3:00:00 AM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    Successfully started 216 patients on IBTROZI® (taletrectinib) in the fourth quarter of 2025, for a total of 432 new patient starts since launch in the second half of June 2025Entered into exclusive licensing and collaboration agreement with Eisai on January 11, 2026, for taletrectinib in Europe and additional countries outside U.S., China and JapanPublished positive Phase 2 study results for safusidenib demonstrating durable responses for the treatment of grade 2 IDH1-mutant gliomaStrong balance sheet with cash, cash equivalents, and marketable securities of $529.2 million as of December 31, 2025Company to host a conference call today at 4:30 pm ETNEW YORK, March 2, 2026 /PRNewswire/ -- Nuva

    3/2/26 4:05:00 PM ET
    $NUVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)

    NEW YORK, Feb. 26, 2026 /PRNewswire/ --This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of the distribution to be paid on February 27, 2026 and cumulative distributions paid fiscal year-to-date. In December 2012, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. The managed distribution policy seeks to deliver the Fund's long-term total return potential through regular monthly distributions declared at a fixed rate per common share. The policy gives the Fund greater flexibility to realize long-term ca

    2/26/26 6:54:00 PM ET
    $CNS
    $RQI
    Investment Managers
    Finance
    Trusts Except Educational Religious and Charitable

    $ALVO
    $AMC
    $BHB
    $CNS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Humacyte Inc.

    SC 13D/A - Humacyte, Inc. (0001818382) (Subject)

    11/20/24 7:10:08 PM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Humacyte Inc.

    SC 13D/A - Humacyte, Inc. (0001818382) (Subject)

    11/18/24 4:10:14 PM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Community Health Systems Inc.

    SC 13G/A - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Subject)

    11/14/24 5:52:10 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care